IHE Radiology Global Regulatory Monitoring Report

Attached is Volume 1, Issue 7 of the IHE Radiology Global Regulatory Monitoring Report. The purpose of this report is to help keep you informed of recent and emerging governmental policy activity affecting radiology. As an international organization, IHE Radiology monitors activity across the United States, Canada, Europe, Japan, and Australia. The report also continues… Read More

IHE Radiology Global Regulatory Monitoring Report

For those that are unfamiliar with some of my other radiology-related activities, I was elected as an IHE Radiology Planning Committee Co-chair earlier in 2026. IHE (Integrating the Healthcare Enterprise) is an international interoperability initiative that helps healthcare computer systems share information cleanly, consistently, and safely. The core idea is simple: IHE does not create… Read More

Using AI to Solve the cmbX Mapping Challenge in the ACR Dose Index Registry

The ACR’s recent introduction of the “cmbX” designation in the Dose Index Registry (DIR) is a meaningful step forward. By separating combination studies, the DIR now allows for more accurate mapping to combination RPIDs—or, when necessary, assignment to RPID88 to remove them from the “unmapped” category. But as many facilities are now discovering, this improvement… Read More

Streamlining cmbX Mapping in the ACR Dose Index Registry

Background On February 17, 2026 the American College of Radiology (ACR) announced an important enhancement to the Dose Index Registry (DIR): the introduction of a “combination study” designation, identified by the cmbX prefix in Study Descriptions. This change represents a meaningful improvement in how the DIR handles multi-part or combined CT exams. The Challenge While… Read More

Important DIR Update – Combination Exam Mapping Changes

To my Dose Registry Clients and Friends, The DIR recently announced changes in how the NRDR maps combination CT studies.  In my opinion, this is one of the most significant and welcome changes to the DIR in years.  See the link immediately below.  https://nrdrsupport.acr.org/support/solutions/articles/11000135515-dir-improves-the-accuracy-of-combination-exams-for-ct The article explains changes to how the DIR records and processes… Read More

CTDIvol vs DLP – a simple explanation

What do they represent? CTDIvol is based on measurements obtained when scanning either a 16cm or 32 cm phantom.   Essentially, it represents scanner output.  DLP is derived from CTDIvol, but incorporates a scan length component.  Both function as reasonable proxies for absorbed dose but do not represent the actual patient dose.  In other words, if… Read More

DIR Corporate-level Aggregate Reports Are Back- Update

As I wrote previously, access to Corporate level Aggregate DIR reports were several restricted after the NRDR changed the organizational structure for facilities submitting data.  One of the biggest changes was the establishment of the “Corporate” account under, and to, which all child sites would be assigned.  Initially, the Corporate level Aggregate reports were not… Read More

Dose Registry Support Services – Our Story

At my direction, our facility began submitting CT dose data to the ACR’s Dose Index Registry® (DIR) in early 2013.  During the following months I learned to use the DIR to identify dose reduction opportunities, and lower our CT doses. In August 2105 The Joint Commission (TJC) updated its diagnostic imaging Elements of Performance requiring… Read More

Tailored DIR Analysis; Is your current solution providing less for more?

The Dose Index Registry (DIR) is a powerful, flexible tool from which facilities can learn a great deal.  The most common use is to use the DIR’s dose comparison reports identify dose reduction opportunities:  Never before have facilities been able to identify dose reduction opportunities so easily. But, there is so much more to glean… Read More

Providing Low-cost, Tailored & Unique Services to Community Hospitals and Radiology Groups

The Dose Index Registry (DIR) is a powerful, flexible tool from which facilities can learn a great deal.  The most common use is to use the DIR’s dose comparison reports identify dose reduction opportunities:  Never before have facilities been able to identify dose reduction opportunities so easily. But, there is so much more to glean… Read More